These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 1582084)

  • 21. c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems.
    Allgayer H; Babic R; Gruetzner KU; Tarabichi A; Schildberg FW; Heiss MM
    J Clin Oncol; 2000 Jun; 18(11):2201-9. PubMed ID: 10829039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different roles for plasminogen activators and metalloproteinases in melanoma metastasis.
    Mueller BM
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 1)():65-80. PubMed ID: 8814995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteases and metastasis: clinical relevance nowadays?
    Decock J; Paridaens R; Cufer T
    Curr Opin Oncol; 2005 Nov; 17(6):545-50. PubMed ID: 16224231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteases and cancer invasion: from belief to certainty. AACR meeting on proteases and protease inhibitors in cancer, Nyborg, Denmark, 14-18 June 1998.
    Blasi F; Stoppelli MP
    Biochim Biophys Acta; 1999 Jan; 1423(1):R35-44. PubMed ID: 9989212
    [No Abstract]   [Full Text] [Related]  

  • 25. The plasminogen activation system in tumour invasion and metastasis.
    de Vries TJ; van Muijen GN; Ruiter DJ
    Pathol Res Pract; 1996 Jul; 192(7):718-33. PubMed ID: 8880873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cellular proteases and invasion].
    Roessner A; Krüger S; Kido A
    Verh Dtsch Ges Pathol; 2000; 84():69-76. PubMed ID: 11217451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of cathepsin B and urokinase plasminogen activator is associated with increased risk of recurrence and metastasis in patients with chondrosarcoma.
    Häckel CG; Krueger S; Grote HJ; Oshiro Y; Hodges S; Johnston DA; Johnson ME; Roessner A; Ayala AG; Czerniak B
    Cancer; 2000 Sep; 89(5):995-1003. PubMed ID: 10964329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteases and protease inhibitors in tumor progression.
    DeClerck YA; Imren S; Montgomery AM; Mueller BM; Reisfeld RA; Laug WE
    Adv Exp Med Biol; 1997; 425():89-97. PubMed ID: 9433492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteolytic enzymes in proliferation and neoplastic metastases formation.
    Gołaszewski Z; Gacko M; Chyczewska E; Chyczewski L; Myćko G; Worowski K
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():48-59. PubMed ID: 9337523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cysteine and serine proteases in gastric cancer.
    Plebani M; Herszènyi L; Cardin R; Roveroni G; Carraro P; Paoli MD; Rugge M; Grigioni WF; Nitti D; Naccarato R
    Cancer; 1995 Aug; 76(3):367-75. PubMed ID: 8625115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Membrane proteases as potential diagnostic and therapeutic targets for breast malignancy.
    Chen WT; Lee CC; Goldstein L; Bernier S; Liu CH; Lin CY; Yeh Y; Monsky WL; Kelly T; Dai M
    Breast Cancer Res Treat; 1994; 31(2-3):217-26. PubMed ID: 7881100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Verapamil inhibits tumor protease production, local invasion and metastasis development in murine carcinoma cells.
    Farías EF; Aguirre Ghiso JA; Ladeda V; Bal de Kier Joffé E
    Int J Cancer; 1998 Dec; 78(6):727-34. PubMed ID: 9833766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of cell adhesion molecules and proteases in tumor invasion and metastasis.
    Bussemakers MJ; Schalken JA
    World J Urol; 1996; 14(3):151-6. PubMed ID: 8806193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of low-risk node-negative breast cancer patients by tumor biological factors PAI-1 and cathepsin L.
    Thomssen C; Oppelt P; Jänicke F; Ulm K; Harbeck N; Höfler H; Kuhn W; Graeff H; Schmitt M
    Anticancer Res; 1998; 18(3C):2173-80. PubMed ID: 9703780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteases in gastrointestinal neoplastic diseases.
    Herszényi L; Plebani M; Carraro P; De Paoli M; Roveroni G; Cardin R; Foschia F; Tulassay Z; Naccarato R; Farinati F
    Clin Chim Acta; 2000 Feb; 291(2):171-87. PubMed ID: 10675722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B.
    Kobayashi H; Ohi H; Sugimura M; Shinohara H; Fujii T; Terao T
    Cancer Res; 1992 Jul; 52(13):3610-4. PubMed ID: 1617632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prognostic role of cisteine and serin proteases in gastriC cancer].
    Herszényi L; Farinati F; Plebani M; Carraro P; Roveroni G; De Paoli M; Cardin R; Naccarato R; Tulassay Z
    Orv Hetil; 1996 Jul; 137(30):1637-41. PubMed ID: 9019701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Matrix-degrading proteases in hormone-dependent breast cancer.
    Dickson RB; Shi YE; Johnson MD
    Breast Cancer Res Treat; 1994; 31(2-3):167-73. PubMed ID: 7881096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental models of invasion and metastasis; can they provide reliable answers for the role of proteases in cancer?
    Ossowski L
    Braz J Med Biol Res; 1996 Sep; 29(9):1099-103. PubMed ID: 9181051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocyte growth factor induces colonic cancer cell invasiveness via enhanced motility and protease overproduction. Evidence for PI3 kinase and PKC involvement.
    Kermorgant S; Aparicio T; Dessirier V; Lewin MJ; Lehy T
    Carcinogenesis; 2001 Jul; 22(7):1035-42. PubMed ID: 11408346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.